Franklin Resources’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Franklin Resources’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-330,000	Closed	-$950K	–	2439
2022 Q2	$950K	Hold	330,000	–	–	﹤0.01%	1552
2022 Q1	$2.07M	Hold	330,000	–	–	﹤0.01%	1405
2021 Q4	$3.68M	Sell	330,000 -3,000	-0.9%	-$41.6K	﹤0.01%	1315
2021 Q3	$5.44M	Sell	333,000 -343,513	-51%	-$6.15M	﹤0.01%	1183
2021 Q2	$12.5M	Buy	676,513 +68,000	+11%	+$1.31M	﹤0.01%	970
2021 Q1	$9.18M	Buy	608,513 +238,095	+64%	+$5.18M	﹤0.01%	989
2020 Q4	$12M	Buy	+370,418	New	+$4.9M	0.01%	926

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Franklin Resources's CDAK Position: Q3 2022 in Review

Franklin Resources sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q3 2022, closing a stake of 330,000 shares — an estimated $950K sold.

Franklin Resources first reported a position in CDAK in Q4 2020 and held it in 7 quarters. The position peaked at $12.5M in Q2 2021. 48 funds tracked by Wall St. Rank hold CDAK as of Q3 2022.

Franklin Resources reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Franklin Resources sold 330,000 Codiak BioSciences, Inc. Common Stock shares in Q3 2022, an estimated $950K.
Franklin Resources first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Franklin Resources's Codiak BioSciences, Inc. Common Stock position peaked at $12.5M in Q2 2021.
48 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2022.

Based on Franklin Resources's 13F filing for Q3 2022, filed 14 Nov 2022.